Victory Capital Management Inc Zynerba Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.31 - $6.54 $10,502 - $20,751	-3,173 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.9 - $6.16 $145 - $308	50 Added 1.6%	3,173 $12,000
Q4 2019 Feb 04, 2020	SELL	$5.61 - $8.57 $4,443 - $6,787	-792 Reduced 20.23%	3,123 $16,000
Q3 2019 Nov 12, 2019	BUY	$7.56 - $15.44 $29,597 - $60,447	3,915 New	3,915 $30,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.